AlbionVC

TransFICC specializes in low-latency connectivity solutions for banks and asset managers trading in Fixed Income and Derivatives markets. It offers a unified API that simplifies access to multiple execution venues, ensuring microsecond timestamping of data and comprehensive audit trails to support best execution requirements.

DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.

Treefera is an AI-driven data management platform specializing in nature-based asset reporting. It integrates satellite, drone, and ground truth data with advanced AI algorithms to provide continuous monitoring, assurance, and risk evaluation for clients involved in carbon credit markets, bioenergy, biofuels, and supply chain businesses. The platform covers over 500 registered forest projects across various jurisdictions, offering real-time environmental and forestry data.

Phasecraft is a UK-based company founded in 2018 by world-class quantum scientists and engineers. They specialize in developing quantum software for intermediate-scale devices and quantum computers, aiming to accelerate practical applications of quantum computing.

Umedeor Ltd is a technology company that specializes in data access for medical research and healthcare delivery. Established in 2017 and headquartered in London, with an additional office in New York, Umedeor develops a platform that automates the creation of prospective patient registries across a global network of healthcare providers. This innovative platform allows research organizations, healthcare providers, care agencies, and charities to efficiently monitor medical records and participate in multiple clinical programs simultaneously, without adding to their operational burden. By facilitating access to high-quality, compliant data, Umedeor supports life science companies in their research and development efforts, as well as post-market activities.

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.

Peppy Health operates an online platform offering specialist support for underserved areas of healthcare such as menopause, fertility and pregnancy, men's health, and women's health. The platform connects users with vetted practitioners, providing personalized care through a secure app.

DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.

Runa is pioneering a first-of-its-kind payment rail capable of sending and accepting digital value at scale. With Runa, companies can pay the people they serve in any form of digital value, anywhere, instantly. The Runa Network provides a wide range of digital payout types including gift cards, prepaid cards, subscriptions, donations, cryptocurrencies and more. Legacy payment mechanisms struggle to adapt to low-volume, high-velocity transactions both locally and globally, such as sending payouts to gig workers, creators, or sending rewards to customers or employees wherever they are. Runa’s infrastructure and network facilitates payouts to these recipients, helping businesses expand their reach, retain their users while modernizing the way in which they manage and transfer money: instantly, internationally, and free of charge for the senders and the recipient. Runa was established as WeGift in October 2016 by Aron Alexander in London, England.

Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. The company specializes in developing an online platform that connects mental health therapists with both children and adults, facilitating access to evidence-based psychological therapies. Healios aims to empower patients and their families by providing a clinician-led online family intervention service that offers interactive psychoeducation for caregivers. By integrating technology with specialized expertise and personal human connection, Healios seeks to enhance the delivery of mental health care and promote behavioral change. Their mission is to transform care delivery, enabling patients, families, and caregivers to move forward and improve their quality of life.

OutThink is a London-based cybersecurity company recognized by Gartner and Forrester for its innovative human risk management platform. The SaaS solution identifies and reduces risky workforce behaviors, transforming employee engagement to build a risk-aware culture.

Toqio is a technology company founded in 2019 by Eduardo Martinez and Michael Galvin, with offices in London, Madrid, and Nairobi. It specializes in providing a platform that enables organizations to develop customized fintech solutions, either as mobile applications or web-based services. Toqio offers software integration tools tailored for the financial industry, facilitating various functions such as digital banking, onboarding, transaction monitoring, and the distribution of financial products and services. Its platform includes a marketplace of partners and supports configuration and customization, allowing companies to rapidly deploy data-driven financial propositions to their customers.

Founded in 2011, Black Swan Data develops an AI-driven consumer intelligence platform. It integrates and analyzes internal and external data, including social media conversations, to provide predictive insights for marketing and trade investments worldwide.

Speechmatics develops speech recognition and automated speech-to-text technology that converts spoken language into written text using machine learning and artificial intelligence. Its platform provides a speech-to-text API for solution and service providers to integrate into their stacks across industries, enabling accurate transcription of voice data regardless of language, demographics, or dialect. The technology generates time-stamped transcripts in multiple languages to support accessibility, discovery, and operational efficiency for media, contact centers, compliance, and ediscovery workflows worldwide.

TransFICC specializes in low-latency connectivity solutions for banks and asset managers trading in Fixed Income and Derivatives markets. It offers a unified API that simplifies access to multiple execution venues, ensuring microsecond timestamping of data and comprehensive audit trails to support best execution requirements.

PerchPeek Limited is an online platform based in London, United Kingdom, that facilitates property renting by connecting tenants with property providers. Founded in 2017, the company leverages artificial intelligence to serve as a home search assistant, streamlining the relocation process for individuals and groups. Its platform offers a range of services, including house-hunting, virtual tours of schools, and assistance with utility setups and shipping quotes. Additionally, PerchPeek provides customer support and a real-time dashboard for HR teams, helping to manage employee relocations and cost-of-living considerations. By guiding users through each stage of their move, PerchPeek enhances the overall experience of finding and settling into a new home.

Brytlyt develops a GPU accelerated database platform, empowering data scientists and decision-makers across industries like telecoms, finance, and logistics. Its patent-pending GPU technology enables instant insights and deep learning model management.

Founded in 2013, Elliptic is a London-based company that specializes in blockchain analytics and compliance. It provides actionable intelligence on cryptocurrency transactions to financial institutions, regulators, and government agencies, aiming to combat illicit activity and ensure regulatory compliance.

Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.

Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. The company specializes in developing an online platform that connects mental health therapists with both children and adults, facilitating access to evidence-based psychological therapies. Healios aims to empower patients and their families by providing a clinician-led online family intervention service that offers interactive psychoeducation for caregivers. By integrating technology with specialized expertise and personal human connection, Healios seeks to enhance the delivery of mental health care and promote behavioral change. Their mission is to transform care delivery, enabling patients, families, and caregivers to move forward and improve their quality of life.

Panaseer is a cloud-based cybersecurity intelligence platform that provides continuous controls monitoring for the enterprise. The platform inventories assets, applications, users and datasets across the IT estate in real time, identifies gaps in controls coverage, aligns security with framework standards, and substantiates regulatory compliance. It automates reporting to reduce manual effort and tailors insights for stakeholders from executives to security analysts. By cleaning, normalizing and unifying entity data, Panaseer enables monitoring of security metrics and prioritization of risk based on business impact, helping security teams automate reporting and improve cyber hygiene across the organization. The solution ingests data from multiple sources in the cloud and on premises to improve risk posture and cyber hygiene practices.

Solidatus is a leading provider of data lineage and conceptual modeling solutions, focused on helping organizations manage their metadata, data, and processes effectively. The company offers software that enables businesses to visualize data flows within their systems, facilitating regulatory compliance, improving governance, and optimizing data landscapes. Solidatus builds interconnected digital maps of organizations, which simplifies complexity and enhances operational efficiency. Its unique approach validates the integrity of AI-generated data and supports transformational change initiatives, making it an essential tool for data-rich and regulated sectors such as finance, pharmaceuticals, and utilities. With a growing global presence, Solidatus operates from its headquarters in London and an office in Singapore, with plans for expansion into the US, Europe, and the Middle East.

Umedeor Ltd is a technology company that specializes in data access for medical research and healthcare delivery. Established in 2017 and headquartered in London, with an additional office in New York, Umedeor develops a platform that automates the creation of prospective patient registries across a global network of healthcare providers. This innovative platform allows research organizations, healthcare providers, care agencies, and charities to efficiently monitor medical records and participate in multiple clinical programs simultaneously, without adding to their operational burden. By facilitating access to high-quality, compliant data, Umedeor supports life science companies in their research and development efforts, as well as post-market activities.

Runa is pioneering a first-of-its-kind payment rail capable of sending and accepting digital value at scale. With Runa, companies can pay the people they serve in any form of digital value, anywhere, instantly. The Runa Network provides a wide range of digital payout types including gift cards, prepaid cards, subscriptions, donations, cryptocurrencies and more. Legacy payment mechanisms struggle to adapt to low-volume, high-velocity transactions both locally and globally, such as sending payouts to gig workers, creators, or sending rewards to customers or employees wherever they are. Runa’s infrastructure and network facilitates payouts to these recipients, helping businesses expand their reach, retain their users while modernizing the way in which they manage and transfer money: instantly, internationally, and free of charge for the senders and the recipient. Runa was established as WeGift in October 2016 by Aron Alexander in London, England.

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.

TransFICC specializes in low-latency connectivity solutions for banks and asset managers trading in Fixed Income and Derivatives markets. It offers a unified API that simplifies access to multiple execution venues, ensuring microsecond timestamping of data and comprehensive audit trails to support best execution requirements.

Concirrus operates a cloud platform that connects diverse data sources and devices, transforming businesses by managing and organizing information from connected products and machines. It offers custom solutions, pre-built applications in asset security, fleet management, smart energy, and patient monitoring, along with an incident monitoring center for theft recovery and securing high-value assets. Serving global clients across healthcare, security, mining, insurance, and other sectors, Concirrus empowers organizations to make data-driven decisions through its intelligence platform Quest.

Hazy is a data technology company that develops an AI-powered platform for synthetic data and automated data anonymization. The platform enables secure, automatic sharing of datasets while identifying and replacing personally identifiable information in evolving datasets, helping data-centric organizations unlock value from data while meeting privacy requirements. Founded in 2017 and based in London, the company aims to enable data to be shared and used more freely, accelerating AI adoption and enhancing business intelligence while maintaining trust.

Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

Speechmatics develops speech recognition and automated speech-to-text technology that converts spoken language into written text using machine learning and artificial intelligence. Its platform provides a speech-to-text API for solution and service providers to integrate into their stacks across industries, enabling accurate transcription of voice data regardless of language, demographics, or dialect. The technology generates time-stamped transcripts in multiple languages to support accessibility, discovery, and operational efficiency for media, contact centers, compliance, and ediscovery workflows worldwide.

Founded in 2013, Elliptic is a London-based company that specializes in blockchain analytics and compliance. It provides actionable intelligence on cryptocurrency transactions to financial institutions, regulators, and government agencies, aiming to combat illicit activity and ensure regulatory compliance.

Koru Kids is a London-based childcare company that operates a platform to connect families with nannies, starting with nanny sharing in Greater London. The company matches households with full-time nannies to families seeking part-time care, enabling flexible, affordable childcare while promoting children's well-being. The platform supports the employment process from candidate search and messaging to interviews and onboarding, including alerts for new nanny profiles and tools to manage payroll, contracts, and tax registration, helping families legally employ a nanny. By focusing on nanny sharing and scalable care solutions, Koru Kids aims to build reliable, quality childcare that fits parents' schedules.

Clear Review Limited is a London-based company that offers a cloud-based performance management and engagement platform designed to facilitate ongoing employee feedback and continuous conversations between employees and managers. Established in 2014 and formerly known as One Touch Apps Limited until its rebranding in August 2019, Clear Review provides a suite of services including check-ins, real-time feedback, aligned SMART objectives, performance reviews, personal development plans, and rapid reporting tools. The platform is utilized across a diverse range of sectors, such as media, technology, financial services, healthcare, government, education, and professional services, among others. Clear Review is committed to empowering HR professionals and employees to enhance their performance and engagement at work, promoting a culture of open communication and collaboration.

Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.

Astroscreen Ltd is a London-based company that specializes in developing a software as a service (SaaS) platform aimed at detecting astroturfing campaigns and social media manipulation. Incorporated in 2018, Astroscreen utilizes advanced machine learning techniques alongside human intelligence to identify fake accounts, botnets, and spam on social networks. Its platform supports disinformation analysts by verifying social media influence engagement and cleaning data streams, thereby enabling clients to combat marketing fraud and protect against harmful manipulation. By providing accurate insights into social media analytics, Astroscreen helps brands maintain their integrity and defend democracy from deceptive practices online.

Avora is a London-based company that specializes in providing a cloud-based augmented analytics platform, enabling organizations to derive value from their data efficiently. The platform leverages artificial intelligence and machine learning to streamline in-depth data analysis, making it accessible even for non-technical users. By consolidating data from various sources and automating anomaly detection, Avora enables quick decision-making and proactive management of business challenges. Its unique approach reduces data preparation and discovery time significantly, allowing users to gain insights in minutes rather than days. Avora serves a diverse range of industries, including retail, financial services, advertising, supply chain, and media, with additional offices in New York and Romania, facilitating enhanced productivity and insight across its client base.

Epsilogen Ltd is an immuno-oncology company based in London, United Kingdom, founded in 2016. The company specializes in developing immunoglobulin E (IgE) antibodies aimed at treating cancer. Epsilogen offers a portfolio of IgE candidates that specifically target cancer antigens such as HER2, EGFR, and PD-L1. Its innovative IgE platform supports the development and validation of novel antibodies, allowing for enhanced potency, improved tumor access, and a prolonged presence in tissue. This focus on IgE-based therapies positions Epsilogen to provide effective treatment options for patients with solid tumors.

Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.

Phrasee Ltd., established in 2015 and headquartered in London, specializes in developing artificial intelligence-driven software solutions for marketing language generation. Its flagship product, Phrasee Pheelings, employs AI algorithms to predict audience emotional responses and generate human-sounding variants for email subject lines, body copies, trigger campaigns, and calls-to-action. By analyzing millions of words and sentences, Phrasee's tailored algorithms create marketing copy that outperforms human-generated content, driving higher opens, clicks, and conversions for its clients.

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.

Hazy is a data technology company that develops an AI-powered platform for synthetic data and automated data anonymization. The platform enables secure, automatic sharing of datasets while identifying and replacing personally identifiable information in evolving datasets, helping data-centric organizations unlock value from data while meeting privacy requirements. Founded in 2017 and based in London, the company aims to enable data to be shared and used more freely, accelerating AI adoption and enhancing business intelligence while maintaining trust.

Panaseer is a cloud-based cybersecurity intelligence platform that provides continuous controls monitoring for the enterprise. The platform inventories assets, applications, users and datasets across the IT estate in real time, identifies gaps in controls coverage, aligns security with framework standards, and substantiates regulatory compliance. It automates reporting to reduce manual effort and tailors insights for stakeholders from executives to security analysts. By cleaning, normalizing and unifying entity data, Panaseer enables monitoring of security metrics and prioritization of risk based on business impact, helping security teams automate reporting and improve cyber hygiene across the organization. The solution ingests data from multiple sources in the cloud and on premises to improve risk posture and cyber hygiene practices.

Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. The company specializes in developing an online platform that connects mental health therapists with both children and adults, facilitating access to evidence-based psychological therapies. Healios aims to empower patients and their families by providing a clinician-led online family intervention service that offers interactive psychoeducation for caregivers. By integrating technology with specialized expertise and personal human connection, Healios seeks to enhance the delivery of mental health care and promote behavioral change. Their mission is to transform care delivery, enabling patients, families, and caregivers to move forward and improve their quality of life.

Koru Kids is a London-based childcare company that operates a platform to connect families with nannies, starting with nanny sharing in Greater London. The company matches households with full-time nannies to families seeking part-time care, enabling flexible, affordable childcare while promoting children's well-being. The platform supports the employment process from candidate search and messaging to interviews and onboarding, including alerts for new nanny profiles and tools to manage payroll, contracts, and tax registration, helping families legally employ a nanny. By focusing on nanny sharing and scalable care solutions, Koru Kids aims to build reliable, quality childcare that fits parents' schedules.

MeiraGTx Holdings is a clinical-stage gene therapy company dedicated to developing and commercializing innovative gene therapy products aimed at transforming the lives of patients with acquired and inherited disorders. The company focuses on addressing serious medical conditions, primarily targeting disorders related to the eye, salivary gland, and central nervous system. Its research and development efforts leverage a portfolio approach, which includes licensing, acquiring, and developing advanced technologies to support a diverse range of product candidates. Key pipeline products include AAV-CNGB3, AAV-CNGA3, and AAV-RPGR, among others. MeiraGTx operates in the United States, the United Kingdom, and the European Union, with plans to expand its focus to develop additional gene therapy treatments for various serious diseases in the future.

Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

Panaseer is a cloud-based cybersecurity intelligence platform that provides continuous controls monitoring for the enterprise. The platform inventories assets, applications, users and datasets across the IT estate in real time, identifies gaps in controls coverage, aligns security with framework standards, and substantiates regulatory compliance. It automates reporting to reduce manual effort and tailors insights for stakeholders from executives to security analysts. By cleaning, normalizing and unifying entity data, Panaseer enables monitoring of security metrics and prioritization of risk based on business impact, helping security teams automate reporting and improve cyber hygiene across the organization. The solution ingests data from multiple sources in the cloud and on premises to improve risk posture and cyber hygiene practices.

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.

Founded in 2011 and headquartered in London, Convertr Media develops a cloud-based customer acquisition platform serving brands/advertisers, publishers, and agencies. The platform enables multi-channel acquisition campaigns with real-time ROI tracking, enhances audience profiles for increased sales revenues, and automates client acquisition campaigns for agencies.

Founded in 2011, Black Swan Data develops an AI-driven consumer intelligence platform. It integrates and analyzes internal and external data, including social media conversations, to provide predictive insights for marketing and trade investments worldwide.

Orchard Therapeutics is a UK-based biopharmaceutical company dedicated to developing and commercializing innovative gene therapies for rare diseases. Its core focus is autologous ex vivo gene therapy, transforming hematopoietic stem cells into a gene-modified drug product for single-administration treatments. The company's portfolio includes Strimvelis, approved by the EMA in 2016, and several programs in advanced registrational studies across various disease areas.

InCrowd Sports Limited is a mobile fan engagement and sports marketing company based in London, United Kingdom. Established in 2014, the company develops club-specific mobile applications that provide real-time content, match analysis, and gamification tools to enhance the in-stadium experience for fans, clubs, and sponsors. InCrowd Sports' technology improves mobile connectivity inside stadiums, allowing fans to interact seamlessly. The company also offers tools for creating mobile sponsorship inventory, enabling brands to engage with fans through various interactive features such as predictors, quizzes, and games. This innovative approach aims to significantly enhance fan engagement and create a more dynamic sporting environment.

Grapeshot, established in 2002, is a software company specializing in contextual intelligence solutions for marketers and advertising agencies. Headquartered in Cambridge, UK, with global offices, it offers a platform that enables real-time targeting, data enrichment, and audience discovery. Grapeshot's key solutions include custom and predictive targeting, brand safety, GDPR compliance, campaign analytics, and audience segmentation. Serving brands, DSPs, media agencies, platforms, publishers, and trading desks, it empowers businesses to improve media efficiency, customer engagement, and brand perception. Post-acquisition by Oracle in 2018, Grapeshot continues to be recognized for its innovative tools, winning awards such as "Digiday's Best Publisher Tool" and "British Media Awards' Ad Provider of the Year."

Panaseer is a cloud-based cybersecurity intelligence platform that provides continuous controls monitoring for the enterprise. The platform inventories assets, applications, users and datasets across the IT estate in real time, identifies gaps in controls coverage, aligns security with framework standards, and substantiates regulatory compliance. It automates reporting to reduce manual effort and tailors insights for stakeholders from executives to security analysts. By cleaning, normalizing and unifying entity data, Panaseer enables monitoring of security metrics and prioritization of risk based on business impact, helping security teams automate reporting and improve cyber hygiene across the organization. The solution ingests data from multiple sources in the cloud and on premises to improve risk posture and cyber hygiene practices.

Abcodia is a biotechnology company specializing in the discovery and validation of molecular biomarkers for disease diagnosis and screening, with a particular focus on cancer. Founded in 2010 and headquartered in Cambridge, UK, Abcodia utilizes its unique longitudinal serum biobank and collaborations with academic institutions like UCL, technology platform providers, and leading diagnostic companies to support the entire diagnostic development process. The company offers Roca Test solutions for early ovarian cancer detection, serving customers across multiple states in the US and the United Kingdom.

Aridhia Informatics Ltd. is a Glasgow-based company that specializes in biomedical informatics and analytic solutions aimed at enhancing stratified medicine and translational research. Founded in 2007, Aridhia offers tools for patient tracking, infection control, and long-term condition management, along with clinical dashboards that provide at-a-glance information for healthcare professionals. The company focuses on integrating patient, clinical, and genomic data to improve the understanding, diagnosis, prevention, and treatment of chronic diseases. By collaborating with clinicians and researchers, Aridhia aims to empower patients to take a more active role in their healthcare while delivering insights into disease trends, risk factors, and treatment impacts to inform public health initiatives. Its partnerships with organizations like GoPivotal, Inc. and Glencoe Software, Inc. further bolster its innovative approach to addressing significant health challenges.

Exco inTouch Ltd specializes in patient engagement and data capture solutions for clinical trials and healthcare programs, operating both in the United Kingdom and internationally. Founded in 2004 and based in Nottingham, the company offers a comprehensive platform, Gather, which facilitates two-way communication between patients, site managers, and study teams throughout the clinical process, all while adhering to study protocols. In addition to its clinical research solutions, Exco inTouch develops disease management programs that involve patients, caregivers, and healthcare professionals. These programs include condition-specific care plans designed to enhance patient understanding of their health conditions, improve adherence to treatment regimens, and support effective condition management. The company's digital health solutions are utilized across various therapeutic areas, including diabetes, dermatology, respiratory diseases, and haemophilia, thereby advancing both patient engagement and data collection in clinical settings.

Mirada Medical Limited is a developer of medical imaging software applications focused on enhancing patient outcomes in various medical fields, including radiology, molecular imaging, and radiation oncology. Founded in 1999 and headquartered in Oxford, United Kingdom, with an additional office in Denver, Colorado, the company provides innovative solutions such as Mirada XD, an enterprise software for nuclear medicine and image fusion; DLCExpert, which offers automated organ-at-risk contouring services; and Mirada IM, designed to support interventional medicine and optimize radioembolization therapy. Mirada's products are utilized in hospitals, imaging centers, and cancer centers globally, facilitating multidisciplinary meetings and enabling healthcare professionals to effectively diagnose, manage, and treat cancer and other diseases through advanced technology. The company distributes its software through direct sales and partnerships with distributors.

Abcodia is a biotechnology company specializing in the discovery and validation of molecular biomarkers for disease diagnosis and screening, with a particular focus on cancer. Founded in 2010 and headquartered in Cambridge, UK, Abcodia utilizes its unique longitudinal serum biobank and collaborations with academic institutions like UCL, technology platform providers, and leading diagnostic companies to support the entire diagnostic development process. The company offers Roca Test solutions for early ovarian cancer detection, serving customers across multiple states in the US and the United Kingdom.

Perpetuum Ltd. is a company based in Southampton, United Kingdom, that specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 as a technology spin-off from the University of Southampton, Perpetuum has developed innovative self-powered wireless sensor solutions designed for condition monitoring in various industries, including rail, oil and gas, chemicals, and power generation. Its flagship products convert mechanical vibration into electrical energy, allowing for the operation of autonomous, maintenance-free wireless sensor nodes that transmit critical data on equipment health and performance. Perpetuum is recognized as the global leader in vibration energy harvesting, continually advancing the practical applications of this technology to enhance operational efficiency and safety in industrial environments.

Proveca Ltd. is a pharmaceutical company based in Daresbury, United Kingdom, founded in 2010. The company specializes in identifying, researching, and licensing off-patent medicines aimed at addressing unmet medical needs, particularly within the pediatric market. Proveca's product portfolio includes formulations for conditions such as sialorrhoea, epilepsy, heart failure, and acute pain management. By developing the necessary clinical data and formulations, Proveca aims to secure Paediatric Use Marketing Authorisation (PUMA), which provides a decade of market protection, along with the potential to obtain Orphan Drug status for additional market exclusivity. The company seeks to commercialize its licensed medicines or sell licenses to larger pharmaceutical firms, ensuring that essential treatments are accessible to children in appropriate formats.

Cisiv provides technology solutions for pharmaceutical, biotech, research organizations and academia, offering Baseline Plus data capture platform for non-interventional studies, enabling sponsors and CROs to run complex multinational studies with improved data quality and workflow. The platform includes a communication platform for study groups, data entry support, translation capabilities, and tools to extract meaningful patient data. It develops a real-world data collection platform designed to support clinical development and late-phase research; offers an integrated platform with configurable tools and workflows for data collection and analysis, along with year-round tiered technical support, to gather and manage evidence while minimizing burden on patients and healthcare practitioners.

Blackbay is a provider of mobility-enabled technologies for supply chain and field service operations. The company designs and implements cloud-based and on-device software to enable real-time visibility, dispatch, routing, and communication across delivery and service workflows. Its products include Delivery Connect, a mobile freight and delivery movement management platform, and Service Connect, a field-service solution with timesheets and parts ordering. Blackbay's solutions are used with handheld devices and back-end infrastructure to connect shippers, drivers, dispatchers, and customers, delivering track-and-trace, scheduling, and automated workflows that improve delivery accuracy, efficiency, and customer communication. The company serves industries such as postal and courier, hub-and-spoke logistics, third-party logistics, facilities management, and manufacturing, enabling mobile workers and fleet operations to operate more effectively worldwide.

Mirada Medical Limited is a developer of medical imaging software applications focused on enhancing patient outcomes in various medical fields, including radiology, molecular imaging, and radiation oncology. Founded in 1999 and headquartered in Oxford, United Kingdom, with an additional office in Denver, Colorado, the company provides innovative solutions such as Mirada XD, an enterprise software for nuclear medicine and image fusion; DLCExpert, which offers automated organ-at-risk contouring services; and Mirada IM, designed to support interventional medicine and optimize radioembolization therapy. Mirada's products are utilized in hospitals, imaging centers, and cancer centers globally, facilitating multidisciplinary meetings and enabling healthcare professionals to effectively diagnose, manage, and treat cancer and other diseases through advanced technology. The company distributes its software through direct sales and partnerships with distributors.

Grapeshot, established in 2002, is a software company specializing in contextual intelligence solutions for marketers and advertising agencies. Headquartered in Cambridge, UK, with global offices, it offers a platform that enables real-time targeting, data enrichment, and audience discovery. Grapeshot's key solutions include custom and predictive targeting, brand safety, GDPR compliance, campaign analytics, and audience segmentation. Serving brands, DSPs, media agencies, platforms, publishers, and trading desks, it empowers businesses to improve media efficiency, customer engagement, and brand perception. Post-acquisition by Oracle in 2018, Grapeshot continues to be recognized for its innovative tools, winning awards such as "Digiday's Best Publisher Tool" and "British Media Awards' Ad Provider of the Year."

Abcodia is a biotechnology company specializing in the discovery and validation of molecular biomarkers for disease diagnosis and screening, with a particular focus on cancer. Founded in 2010 and headquartered in Cambridge, UK, Abcodia utilizes its unique longitudinal serum biobank and collaborations with academic institutions like UCL, technology platform providers, and leading diagnostic companies to support the entire diagnostic development process. The company offers Roca Test solutions for early ovarian cancer detection, serving customers across multiple states in the US and the United Kingdom.

Cisiv provides technology solutions for pharmaceutical, biotech, research organizations and academia, offering Baseline Plus data capture platform for non-interventional studies, enabling sponsors and CROs to run complex multinational studies with improved data quality and workflow. The platform includes a communication platform for study groups, data entry support, translation capabilities, and tools to extract meaningful patient data. It develops a real-world data collection platform designed to support clinical development and late-phase research; offers an integrated platform with configurable tools and workflows for data collection and analysis, along with year-round tiered technical support, to gather and manage evidence while minimizing burden on patients and healthcare practitioners.

Proveca Ltd. is a pharmaceutical company based in Daresbury, United Kingdom, founded in 2010. The company specializes in identifying, researching, and licensing off-patent medicines aimed at addressing unmet medical needs, particularly within the pediatric market. Proveca's product portfolio includes formulations for conditions such as sialorrhoea, epilepsy, heart failure, and acute pain management. By developing the necessary clinical data and formulations, Proveca aims to secure Paediatric Use Marketing Authorisation (PUMA), which provides a decade of market protection, along with the potential to obtain Orphan Drug status for additional market exclusivity. The company seeks to commercialize its licensed medicines or sell licenses to larger pharmaceutical firms, ensuring that essential treatments are accessible to children in appropriate formats.

Workshare is a company that provides a cloud-enabled platform designed to facilitate the comparison, protection, and sharing of high-stakes documents across various devices. Its innovative solutions allow content owners to track and compare amendments made by multiple contributors, ensuring secure and collaborative workflows. The company's offerings include tools for viewing, commenting, searching, storing, and managing files, catering to the needs of professionals in dynamic work environments. Headquartered in London, Workshare also has offices in the United States and Australia, serving over two million users in 70 countries. The platform is accessible on desktop, mobile, and tablet devices, enabling effective collaboration and control over document changes.

Abcodia is a biotechnology company specializing in the discovery and validation of molecular biomarkers for disease diagnosis and screening, with a particular focus on cancer. Founded in 2010 and headquartered in Cambridge, UK, Abcodia utilizes its unique longitudinal serum biobank and collaborations with academic institutions like UCL, technology platform providers, and leading diagnostic companies to support the entire diagnostic development process. The company offers Roca Test solutions for early ovarian cancer detection, serving customers across multiple states in the US and the United Kingdom.

Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Oxsensis Ltd. is a manufacturer of non-electrical sensor systems that specialize in optical sensors for measuring pressure, temperature, and vibration in extreme environments. Founded in 2003 and headquartered in Didcot, United Kingdom, the company also operates additional offices in the United States, Russia, China, and Japan. Its product offerings include advanced optical instrumentation such as the Wave-Phire Dynamic Pressure Transducer, which is designed for harsh conditions like gas turbines, and the i-Phire 4 Channel Optical Interrogator Unit, which converts optical signals into voltage signals for dynamic pressure measurements. Oxsensis serves a diverse range of industries including aerospace, power generation, oil and gas, and space, focusing on applications that require high sensitivity and immunity to electromagnetic interference. The company's innovative solutions contribute to precision controls and health monitoring in high-temperature and safety-critical environments.

Oxsensis Ltd. is a manufacturer of non-electrical sensor systems that specialize in optical sensors for measuring pressure, temperature, and vibration in extreme environments. Founded in 2003 and headquartered in Didcot, United Kingdom, the company also operates additional offices in the United States, Russia, China, and Japan. Its product offerings include advanced optical instrumentation such as the Wave-Phire Dynamic Pressure Transducer, which is designed for harsh conditions like gas turbines, and the i-Phire 4 Channel Optical Interrogator Unit, which converts optical signals into voltage signals for dynamic pressure measurements. Oxsensis serves a diverse range of industries including aerospace, power generation, oil and gas, and space, focusing on applications that require high sensitivity and immunity to electromagnetic interference. The company's innovative solutions contribute to precision controls and health monitoring in high-temperature and safety-critical environments.

Dexela is a company focused on developing advanced 3-D breast imaging technology aimed at the early detection of breast cancer. It offers a range of products, including the DexTop Digital Mammography Workstation, which enhances screening workflow and performance, and a 3D reconstruction engine provided to original equipment manufacturer (OEM) partners under licensing agreements. The company manufactures flat panel CMOS X-ray detectors utilized in various medical applications, such as mammography, tomosynthesis, breast CT, and dental imaging, as well as in scientific and non-destructive testing applications. In addition to its product offerings, Dexela provides consulting services related to digital tomosynthesis and optimal 3D data reconstruction. Founded in 2003 and headquartered in London, the company also maintains an X-ray research and development facility in Sudbury, Massachusetts.

Blackbay is a provider of mobility-enabled technologies for supply chain and field service operations. The company designs and implements cloud-based and on-device software to enable real-time visibility, dispatch, routing, and communication across delivery and service workflows. Its products include Delivery Connect, a mobile freight and delivery movement management platform, and Service Connect, a field-service solution with timesheets and parts ordering. Blackbay's solutions are used with handheld devices and back-end infrastructure to connect shippers, drivers, dispatchers, and customers, delivering track-and-trace, scheduling, and automated workflows that improve delivery accuracy, efficiency, and customer communication. The company serves industries such as postal and courier, hub-and-spoke logistics, third-party logistics, facilities management, and manufacturing, enabling mobile workers and fleet operations to operate more effectively worldwide.

ClusterSeven Ltd. is a software company specializing in enterprise-wide spreadsheet and data management solutions, primarily serving financial institutions and reporting divisions. Established in 2003 and headquartered in London, with an additional office in New York, the company offers products such as the ClusterSeven Enterprise Spreadsheet Manager and the ClusterSeven Access Database Manager. These tools monitor and manage business-critical operational spreadsheets and Microsoft Access databases, facilitating governance, risk management, and regulatory compliance. ClusterSeven's software identifies, tracks, and classifies the potential risks associated with individual spreadsheets, providing clients with enhanced oversight and transparency. The company's target sectors include capital markets, retail banking, asset management, hedge funds, insurance, energy, and pharmaceuticals, as well as audit firms.

Bango plc is a technology company based in Cambridge, United Kingdom, specializing in mobile payment solutions for content and services. Founded in 1999, Bango develops, markets, and sells technology that facilitates the marketing and sale of products directly to mobile phone users. The company operates through two segments: End User Activity and Data Activity. Its key offering, the Bango Payment Platform, enables app stores and content providers to establish billing connections with mobile operators globally, thereby streamlining the payment process for users. In addition to this platform, Bango offers products such as Bango Marketplace, which aids developers in targeting specific customer audiences, and Bango Resale, which helps merchants acquire and retain customers through global partnerships. The company also features Audiens, a mobile data exchange platform, and partners with leading global stores and payment providers to enhance user engagement and revenue generation. Bango's operations extend across the United Kingdom, European Union, the United States, Canada, and internationally.